Prudential plc’s iShares Biotechnology ETF IBB Stock Holding History

Prudential plc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,750	Closed	-$1.42M	–	778
2024 Q4	$1.42M	Sell	10,750 -3,310	-24%	-$465K	0.01%	449
2024 Q3	$2.05M	Buy	14,060 +920	+7%	+$133K	0.01%	394
2024 Q2	$1.8M	Sell	13,140 -2,430	-16%	-$324K	0.01%	406
2024 Q1	$2.14M	Buy	+15,570	New	+$2.13M	0.02%	393
2023 Q4	–	Sell	-14,813	Closed	-$1.81M	–	886
2023 Q3	$1.81M	Sell	14,813 -2,957	-17%	-$376K	0.02%	400
2023 Q2	$2.26M	Buy	+17,770	New	+$2.31M	0.03%	361
2023 Q1	–	Sell	-18,750	Closed	-$2.46M	–	885
2022 Q4	$2.46M	Sell	18,750 -72,957	-80%	-$9.43M	0.03%	323
2022 Q3	$10.7M	Buy	91,707 +86,850	+1,788%	+$10.8M	0.17%	80
2022 Q2	$571K	Buy	+4,857	New	+$577K	0.01%	523
2020 Q4	–	Sell	-3,800	Closed	-$515K	–	626
2020 Q3	$515K	Buy	3,800 +1,590	+72%	+$216K	﹤0.01%	510
2020 Q2	$302K	Buy	+2,210	New	+$282K	﹤0.01%	540

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Prudential plc's IBB Position: Q1 2025 in Review

Prudential plc sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 10,750 shares — an estimated $1.42M sold.

Prudential plc first reported a position in IBB in Q2 2020 and held it in 11 quarters. The position peaked at $10.7M in Q3 2022. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Prudential plc reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
Prudential plc sold 10,750 iShares Biotechnology ETF shares in Q1 2025, an estimated $1.42M.
Prudential plc first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 11 quarters.
Prudential plc's iShares Biotechnology ETF position peaked at $10.7M in Q3 2022.
831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Prudential plc's 13F filing for Q1 2025, filed 13 May 2025.